908 Devices: The Bull Vs. Bear Tug Of War

04:39am, Tuesday, 14'th Feb 2023
908 Devices is a highly rated stock by Wall Street analysts. Seeking Alpha quant ratings state the stock "is at a high risk of performing badly."
908 Devices Inc. (NASDAQ:MASS ) Q3 2022 Results Conference Call November 14, 2022 8:30 AM ET Company Participants Kelly Gura - IR Kevin Knopp - CEO and Co-Founder Joe Griffith - CFO Conference Call Pa

Why 908 Devices Stock Is Sinking Today

11:44am, Monday, 14'th Nov 2022
Investors didn't like the medical device maker's update.
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate
908 Devices Inc. (NASDAQ:MASS ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer & Co-Founder Joe G
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report finan
908 Devices, Inc. (NASDAQ:MASS ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Kelly Gura - Investor Relations Kevin Knopp - Chief Executive Officer & Co-Founder Joe Gr
908 Devices Inc. (MASS) delivered earnings and revenue surprises of 0% and 8.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report finan

Why 908 Devices Stock Rocketed 15% Higher Today

10:58pm, Tuesday, 08'th Mar 2022 The Motley Fool
The niche healthcare company delivers a pair of convincing beats in its fourth quarter results.

Why 908 Devices Stock Rocketed 15% Higher Today

05:58pm, Tuesday, 08'th Mar 2022
The niche healthcare company delivers a pair of convincing beats in its fourth quarter results.
Gainers: Voyager Therapeutics VYGR +22%. 908 Devices (MASS) +16%. Viemed Healthcare VMD +10%
908 Devices Inc''s (NASDAQ: MASS ) Q4 FY21 revenue increased 177% Y/Y to $15.8 million , beating the consensus of $15.11 million. The increase was primarily driven by handheld revenue that increased 262%, mainly related to shipments to the US Army under the multi-year purchase order. Desktop revenue grew 53% Y/Y because of … Full story available on Benzinga.com
Futures Rebound On "Massive" EU Bond Stimulus Plan; Nickel Halted After Record Surge, Gold Over $2000 Futures rebounded from yesterday huge loss, and after touching a session low of 4,138, S&P futures bounced shortly after the European when Bloomberg reported that the European Union was set to reveal a quasi "Marshall Plan" this week to issue issue "potentially massive” joint bonds to fund energy and defense and help counter the fiscal fallout from Russia’s invasion of Ukraine (how Europe will do that at a time when QE is ending and buyers for global debt are shrinking fast amid surging rates remains unclear). S&P 500 futures gained 0.7% following the benchmark index’s biggest loss since October 2020, while Dow futures rose 0.6%. Contracts on the Nasdaq 100 were up 0.6% at 7:15 a.m. Bonds and the dollar dropped, and the euro strengthened. The commodity melt up continued: nickel was halted on the LME after soaring 250%, oil traded just shy of $130 and gold was above $2000. The EU''s bond-sale proposal may be presented as soon as next week, according to Bloomberg.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE